The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients using other diabetes drugs such as SGLT-2 and DPP-4.
Hair loss risk goes up on GLP-1 drugs, BMJ study finds
- 2026-07-23, 3:39 PM
- globalnews.ca
- 0
No comments